House Republicans Debating Extension of Expiring ACA Enhanced Premium Subsidies
House Republican leaders debate extending expiring ACA enhanced premium subsidies amid potential premium spikes and internal party disagreements.
House Republican leaders debate extending expiring ACA enhanced premium subsidies amid potential premium spikes and internal party disagreements.
LendingTree survey reveals rising auto insurance costs are causing increased uninsured rates and coverage reductions, with drivers cutting expenses to afford policies.
UnitedHealth expects 78% of members in Medicare Advantage plans rated four stars or higher for 2026, supporting government reimbursements and financial outlook amid cost pressures.
Medicare enrollment decisions between Advantage plans and traditional coverage are increasingly causing social tensions among seniors, fueled by misinformation and financial concerns. This dynamic affects personal relationships and highlights the complexities in senior healthcare insurance choices.
Elevance Health and leading insurers recalibrate Medicare Advantage plans and Part D coverage amid rising costs and regulatory shifts, focusing on risk management and compliance.
U.S. annuity sales reached a record $119.5 billion in Q2 2025, fueled by product innovation and growing demand for guaranteed retirement income, according to LIMRA.
LendingTree survey shows almost all car owners can lower auto insurance premiums by comparing rates, highlighting rising premium dissatisfaction and the value of shopping around.
Key September 2025 updates on U.S. healthcare funding, CDC leadership changes, AI in healthcare, Medicare and Medicaid policies, and COVID-19 vaccine authorization shifts impacting insurers and providers.
Explore the implications of the 2025 decision on ACA enhanced tax credits that impacts health insurance affordability for 24 million Americans and federal health policy.
Congress returns from recess with five key U.S. health policy priorities including FY26 appropriations, OTC drug fee program reauthorization, drug pricing reform, Medicare/Medicaid extenders, and ACA tax credits.